On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc

In this issue

Home Eurosurveillance Edition  2014: Volume 19/ Issue 25 Article 1
Back to Table of Contents
Download (pdf)

Eurosurveillance, Volume 19, Issue 25, 26 June 2014
Epidemiological and genetic investigations of human-to-human transmission of zoonotic influenza viruses
  1. Department of Viroscience, Postgraduate School of Molecular Medicine, Erasmus Medical Center, Rotterdam, the Netherlands

Citation style for this article: Herfst S, Fouchier R. Epidemiological and genetic investigations of human-to-human transmission of zoonotic influenza viruses. Euro Surveill. 2014;19(25):pii=20840. Article DOI:
Date of submission: 22 June 2014

Of the over 1,400 species of infectious organisms known to be pathogenic to humans, 60% are zoonotic, i.e. transmissible from animals to humans [1]. We therefore continuously face the threat of newly emerging pathogens with a major health impact. In the last decade, viral zoonoses have resulted in numerous human cases of infection with e.g. influenza A viruses, Ebola virus, Nipah virus, Hendra virus, severe acute respiratory syndrome (SARS) coronavirus, and Middle-East respiratory syndrome (MERS) coronavirus. While these zoonotic viruses often caused severe disease and deaths in humans, they generally did not represent global health threats as the viruses lacked the ability of sustained human-to-human transmission. However, some of these viruses might adapt to replicate in and spread between humans, to cause pandemics. This is true in particular for respiratory viruses associated with recent zoonotic outbreaks that belong to families that also contain viruses that are endemic in humans and thus have been shown to possess pandemic potential in the past (Figure). Monitoring and predicting which of the various zoonotic viruses have the potential to cross the species barrier and emerge in humans globally has become a major topic in infectious disease research.

Figure. Wild aquatic birds and bats are thought to be the reservoir for many virus families in nature

Wildlife can host an enormous diversity of viruses, which generally do not cause severe disease in these reservoir hosts. Bats have been recognised as reservoir hosts of viruses of the Filoviridae, Paramyxoviridae, and Coronaviridae families [2,3], while wild birds harbour the greatest diversity of influenza A viruses. Recently, close relatives of avian influenza A virus were also found in bats [4]. Occasionally, viruses are transmitted from their reservoir hosts to other animal species, intermediate hosts, from which the viruses may subsequently be more efficiently transmitted to humans, e.g. as a consequence of more frequent contact. Unfortunately, very little is known about the genetic and phenotypic viral and host traits that facilitate interspecies transmission. In addition, knowledge on the mechanisms by which these zoonotic viruses may subsequently adapt to efficient replication and spread in humans is lacking. Recently, progress has been made towards understanding the genetic and phenotypic requirements of avian influenza viruses to become transmissible in ferrets [5-9].

Influenza A viruses are among the most intensively studied viruses when it comes to host range and transmission. The reason is that influenza A virus zoonoses and pandemics occur relatively frequently compared with other virus families. Influenza A viruses have been isolated from many hosts, but wild birds in the orders Anseriformes (ducks, geese and swans) and Charadriiformes (gulls, terns and waders) as well as bats are thought to form the virus reservoirs in nature (Figure). At least 18 subtypes of the influenza virus surface glycoprotein haemagglutinin (HA or H) and 11 subtypes of neuraminidase (NA or N) have been detected in the reservoirs [4]. In the last century, only influenza A viruses of subtypes H1N1 (in 1918 and 2009), H2N2 (1957), and H3N2 (1968) have spilled over from wild birds to poultry or pigs and subsequently triggered a pandemic, with or without the requirement for prior host adaptation or reassortment (i.e. genetic mixing of gene segments). However, avian influenza viruses circulating in poultry (e.g. of subtypes H5, H6, H7, H9, and H10) have occasionally crossed the species barrier to infect humans, raising concerns of a new pandemic threat. The continuing circulation of highly pathogenic avian influenza (HPAI) H5N1 viruses in poultry in Asia and the Middle East has resulted in hundreds of millions of poultry deaths. Cross-species transmission events of H5N1 virus have been reported for several species of wild birds and mammals, including humans (Figure). However, sustained human-to-human transmission has not yet been described.

A study that appears in the current issue of Eurosurveillance by Chea and colleagues investigated two cases of human influenza A(H5N1) virus infection in Cambodia [10]. After the post-mortem diagnosis of influenza A(H5N1) virus infection in a mother and her child, the authors performed a follow-up study of individuals who had been in contact with the two cases. The mother and child were assumed to have been infected from a common poultry source. Although there were no poultry samples available for retrospective laboratory confirmation of H5N1 virus infection, poultry in and around the household had started to die before disease onset of the cases. Respiratory specimens from all contact cases tested negative by RT-PCR for influenza A(H5N1) virus, and no H5N1 antibodies were detected in follow-up sera of contacts. Based on this extensive epidemiological investigation, there was no evidence of human-to-human transmission between the cases or their contacts. The authors conclude that the two cases were most probably exposed to a common source of contaminated environment. 

Similar clinical, virological, and epidemiological investigations were performed by Xiao et al. [11] and Hu et al. [12], but for laboratory-confirmed cases of infection with influenza A(H7N9) virus. Since the emergence of the H7N9 virus in February 2013, only one possible human-to-human transmission event had been described [13]. Here, Xiao and colleagues describe the probable transmission of H7N9 virus from a father to his five year-old child after he worked on a wet market contaminated with H7N9 virus [11]. Disease onset in the child was 10 days later than in the father, and virus was detected in the child several days later as well. The child reportedly did not have contact with poultry in the 12 days before onset of the disease. Investigations of 40 close contacts did not result in the detection of additional cases of infection. Hu et al. describe a similar case of human-to-human transmission from a woman who also contracted influenza A(H7N9) virus at a contaminated wet market and probably transmitted the virus to her husband [12]. The man reportedly never visited wet markets and had not purchased or eaten poultry in the two weeks before the onset of his illness. Onset of disease and detection of the virus in the man occurred approximately one week later than in his wife. Again, 27 close contacts were followed up, but they all turned out to be H7N9-negative. These studies thus present two probable cases of human-to-human transmission of H7N9 virus. In both studies, high nucleotide sequence identity between the viruses from the linked patients was in agreement with this assumption. In the first study, the virus could further be linked genetically to an environmental sample [11]. Although the H7N9 virus has been shown to have some ability of airborne transmission (via aerosol and respiratory droplets) between ferrets [14-18], the human cases are most likely to have occurred through direct contact transmission between family members.

Qi et al. describe the potential origin and genetic diversity of the most recently identified zoonotic influenza virus subtype, H10N8, which was detected in a patient that visited a poultry market a few days before onset of illness [19]. Phylogenetic analysis of the viruses isolated from the patient and the poultry market showed that six genes had the same genetic origin, but the PB1 and PB2 genes (that are part of the viral polymerase complex) were of a different origin. These two genes from the human and chicken virus may be derived from H9N2 chicken and H7 duck influenza viruses, respectively. The genetic differences between the internal genes of the human and chicken viruses suggest that H10N8 viruses continue to undergo reassortment, as reported previously for H7N9 virus. The authors suggest that the H10N8 viruses have become established in poultry and speculate that the diversity of the H10N8 viruses may be much higher than reported so far.

Interestingly, the PB2 gene of the human H10N8 virus contained an E627K mutation, which is a well-known mammalian adaptation mutation associated with virulence and transmission of influenza viruses in mammals, and which was absent in the avian H10N8 strain. This same mutation was also noted in a fifth paper on influenza virus zoonosis in this issue of Eurosurveillance by Wang et al. [20]. Based on analyses of large numbers of full virus genome sequences, these authors propose an evolutionary history of H7N9 viruses, involving continuous amino acid substitutions and reassortment events. According to the authors, reassortment events resulted in at least 26 genotypes. Additional host adaptation of H7N9 viruses resulted in the deletion of five amino acid residues from the NA stalk region and changes in the receptor binding site, resulting in increased affinity for human-type receptors. Finally, the well-known mammalian adaptation mutations in the polymerase complex protein PB2 were acquired, which may allow the viruses to replicate more efficiently in the upper respiratory tract of mammalian hosts. The authors conclude that due to this host adaptation process, the pandemic potential of influenza A(H7N9) is higher than that of any other known avian influenza virus. However, it should be noted that the pandemic risk of influenza virus strains may not be equal to their zoonotic risk, and that different influenza virus subtypes or lineages may require different genetic or phenotypic changes to cause zoonoses and pandemics.

Recently, the United States Centers for Disease Control and Prevention developed an inventory of amino acid substitutions in H5N1 viruses linked to critical phenotypic changes. It supports a molecular approach for surveillance and is useful for identifying genetic changes that may affect phenotypic traits of importance such as virulence, (mammalian) host adaptation, polymerase activity, airborne transmissibility etc. [21]. In geographical locations where viruses already have some of the critical mutations associated with mammalian adaptation and transmission, intensified surveillance is key for monitoring the emergence of viruses with potentially high impact. As previously described by Russell et al., deep sequencing of avian, other non-human, and human virus samples, preferably collected at multiple time points, is necessary to better characterise the likelihood of emergence of viruses with an increased public health risk [22]. Additional studies are also needed to better link the genetic changes in influenza viruses of various subtypes with the phenotypic changes that affect within-host fitness and between-host transmissibility. Furthermore, additional experiments are needed to determine the effect of mutations that may affect transmission of newly emerging influenza virus subtypes in humans [22]. Because many substitutions may be functionally equivalent to those described previously, and because the effect of such substitutions may be dependent on the virus backbone, sequence-based virus surveillance alone may be misleading. Therefore, surveillance studies and epidemiological investigations may be improved further by including virus phenotyping assays, using relatively simple methods as described previously for airborne transmissible H5N1 [5].

The five publications in the current issue of Eurosurveillance on the potential transmissibility and evolution of influenza viruses highlight the impact of these zoonotic viruses on global health. Surprisingly little is known about the routes and mechanisms of virus transmission. As a consequence of these knowledge gaps, key questions in public health such as “Can newly emerging viruses acquire the ability of human-to-human transmission to trigger a pandemic?” remain unanswered. Increased knowledge is important to predict risks and to adapt pharmaceutical and non-pharmaceutical intervention strategies to prevent outbreaks or pandemics. Currently, we appear to rely on humans as sentinels for virus outbreaks in animals and often apply a reactive rather than pro-active approach to limit the impact of emerging virus infections. Implementation of the One Health concept as an approach to overcome some of the difficulties, including efforts to improve laboratory capacity and surveillance systems in humans and animals, may limit the impact of zoonotic and pandemic threats in the future.

Conflict of interest
None declared


Authors’ contributions
Sander Herfst and Ron Fouchier wrote the manuscript.


  1. Taylor LH, Latham SM, Woolhouse ME. Risk factors for human disease emergence. Philos Trans R Soc Lond B Biol Sci. 2001;356(1311):983-9.
    PMid:11516376 PMCid:PMC1088493 
  2. Drexler JF, Corman VM, Müller MA, Maganga GD, Vallo P, Binger T, et al. Bats host major mammalian paramyxoviruses. Nat Commun. 2012;3:796.
    PMid:22531181 PMCid:PMC3343228 
  3. Vijaykrishna D, Smith GJ, Zhang JX, Peiris JS, Chen H, Guan Y. Evolutionary insights into the ecology of coronaviruses. J Virol. 2007;81(8):4012-20.
    PMid:17267506 PMCid:PMC1866124 
  4. Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, et al. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013;9(10):e1003657.
    PMid:24130481 PMCid:PMC3794996 
  5. Linster M, van Boheemen S, de Graaf M, Schrauwen EJ, Lexmond P, Manz B, et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell. 2014;157(2):329-39.
  6. Sutton TC, Obadan A, Lavigne J, Chen H, Li W, Perez DR. Genome rearrangement of influenza virus for anti-viral drug screening. Virus Res. 2014;189C:14-23.
  7. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science. 2012;336(6088):1534-41.
  8. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature. 2012;486(7403):420-8.
    PMid:22722205 PMCid:PMC3388103
  9. Chen LM, Blixt O, Stevens J, Lipatov AS, Davis CT, Collins BE, et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology. 2012;422(1):105-13.
  10. Chea N, Yi SD, Rith S, Seng H, Ieng V, Penh C, et al. Two clustered cases of confirmed influenza A(H5N1) virus infection, Cambodia, 2011. Euro Surveill. 2014;19(25):pii=20839.
  11. Xiao XC, Li KB, Chen ZQ, Di B, Yang ZC, Yuan J, et al. Transmission of avian influenza A(H7N9) virus from father to child: a report of limited person-to-person transmission, Guangzhou, China, January 2014. Euro Surveill. 2014;19(25):pii=20837.
  12. Hu J, Zhu Y, Zhao B, Li J, Liu L, Gu K, et al. Limited human-to-human transmission of avian influenza A (H7N9)virus, Shanghai, China, March to April 2013. Euro Surveill. 2014;19(25):pii=20838. 
  13. Qi X, Qian YH, Bao CJ, Guo XL, Cui LB, Tang FY, et al. Probable person to person transmission of novel avian influenza A (H7N9) virus in Eastern China, 2013: epidemiological investigation. BMJ. 2013;347:f4752.
    PMid:23920350 PMCid:PMC3805478
  14. Watanabe T, Kiso M, Fukuyama S, Nakajima N, Imai M, Yamada S, et al. Characterization of H7N9 influenza A viruses isolated from humans. Nature. 2013;501(7468):551-5.
    PMid:23842494 PMCid:PMC3891892
  15. Richard M, Schrauwen EJ, de Graaf M, Bestebroer TM, Spronken MI, van Boheemen S, et al. Limited airborne transmission of H7N9 influenza A virus between ferrets. Nature. 2013;501(7468):560-3.
    PMid:23925116 PMCid:PMC3819191
  16. Belser JA, Gustin KM, Pearce MB, Maines TR, Zeng H, Pappas C, et al. Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice. Nature. 2013(7468);501:556-9.
  17. Zhang Q, Shi J, Deng G, Guo J, Zeng C, He X, et al. H7N9 influenza viruses are transmissible in ferrets by respiratory droplet. Science. 2013;341(6144):410-4.
  18. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, Yoon SW, et al. Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science. 2013;341(6142):183-6.
  19. Qi W, Zhou X, Shi W, Huang L, Xia W, Liu D, et al. Genesis of the novel human-infecting influenza A(H10N8) virus and potential genetic diversity of the virus in poultry, China. Euro Surveill. 2014;19(25):pii=20841.
  20. Wang D, Yang L, Gao R, Zhang X, Tan Y, Wu A, et al. Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013
  21. Centers for Disease Control and Prevention (CDC). H5N1 genetic changes inventory: a tool for influenza surveillance and preparedness. Atlanta: CDC; 2012. Available from:
  22. Russell CA, Fonville JM, Brown AE, Burke DF, Smith DL, James SL, et al. The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host. Science. 2012;336(6088):1541-7.
    PMid:22723414 PMCid:PMC3426314

Back to Table of Contents
Download (pdf)

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.